Guangzhou Wondfo BiotechLtd

SZSE:300482 Stock Report

Mkt Cap: CN¥17.2b

Guangzhou Wondfo BiotechLtd Future Growth

How is Guangzhou Wondfo BiotechLtd forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-6.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

SZSE:300482 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20244,9571,223N/A1,0563
12/31/20234,7361,141N/A1,3874
12/31/20225,7511,429N/A1,3423
9/30/20225,5501,2479051,472N/A
6/30/20225,5381,2578981,461N/A
3/31/20225,2901,383-270287N/A
12/31/20213,361634208665N/A
9/30/20213,14569518621N/A
6/30/20213,060741-1557N/A
3/31/20212,956692113594N/A
12/31/20202,8116346421,062N/A
9/30/20202,821663657886N/A
6/30/20202,7116308851,053N/A
3/31/20202,172413595775N/A
12/31/20192,072387131310N/A
9/30/20191,921375175329N/A
6/30/20191,817352137296N/A
3/31/20191,74832597232N/A
12/31/20181,650308117248N/A
9/30/20181,54228069198N/A
6/30/20181,49826475175N/A
3/31/20181,32323170186N/A
12/31/20171,14521156169N/A
9/30/2017921181-4651N/A
6/30/2017747174-26100N/A
3/31/201762415427116N/A
12/31/201654714524112N/A
9/30/2016525158103143N/A
6/30/2016486147N/A141N/A
3/31/2016450131N/A145N/A
12/31/2015429125N/A132N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300482's earnings are forecast to decline over the next 3 years (-6.5% per year).

Earnings vs Market: 300482's earnings are forecast to decline over the next 3 years (-6.5% per year).

High Growth Earnings: 300482's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 300482's revenue is expected to decline over the next 3 years (-7.4% per year).

High Growth Revenue: 300482's revenue is forecast to decline over the next 3 years (-7.4% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 300482's Return on Equity is forecast to be low in 3 years time (18%).


Discover growth companies